Wuhan Dr Laser Technology Corp.Ltd(300776) 426 disclose the annual report of 2021. In 2021, the operating revenue reached 1.257 billion yuan, a year-on-year increase of 17.21%; The net profit attributable to the shareholders of the listed company was 381 million yuan, a year-on-year increase of 2.11%; The basic earnings per share is RMB 6.6. It is proposed to distribute a cash dividend of 7.50 yuan (including tax) for every 10 shares to all shareholders and increase 6 shares for every 10 shares to all shareholders with capital reserve.
Wuhan Dr Laser Technology Corp.Ltd(300776) said that during the reporting period, guided by the future development strategy and under the guidance of national policies, the company made continuous efforts to achieve self breakthrough, guided by market demand, and based on the company’s technical precipitation and experience accumulation in R & D, supply chain, sales and service over the years, integrated the resources of R & D centers in Wuhan, Wuxi and Tel Aviv, Israel, through continuous technology and product innovation, Improve product quality and supply chain rapid response ability, and implement product brand strategy.
On the one hand, the company continues to focus on its main business and actively explore the fields of consumer electronics, new displays and integrated circuits.
During the reporting period, the company’s perc laser ablation equipment and Se laser doping equipment continued to maintain stable growth, driving the rapid growth of the company’s main business income. The company has formed a solution knowledge base capable of professional and rapid response to customer needs, as well as the design ability of automation equipment, which has laid a foundation for the company to extend to precision laser processing equipment in other fields such as high-end consumer electronics, new displays and integrated circuits.
On the other hand, the company continued to increase R & D investment and enhance its technological innovation ability. During the reporting period, the company’s R & D expenditure was 103 million yuan, an increase of 83.74% over the same period last year. As of December 31, 2021, Wuhan Dr Laser Technology Corp.Ltd(300776) and its subsidiaries have 166 domestic and foreign patents in total.
On April 26, Wuhan Dr Laser Technology Corp.Ltd(300776) also disclosed the first quarterly report of 2022. In the first quarter, the operating revenue was 311 million yuan, a year-on-year increase of 13.25%; The net profit attributable to the shareholders of the listed company was 929872 million yuan, a year-on-year increase of 26.37%.
